This Growth Stock Is Down Over 40% in 2026. Will Investors Regret Not Buying the Dip?

Zscaler reported $3.5 billion in annual recurring revenue for fiscal Q3, up 25% year over year, but the stock fell 31% after management warned that fiscal 2027 ARR growth could slow to 16% following the departure of two senior sales executives. The company is expanding its zero-trust platform across branches and AI agents, and its customer base in the Zero Trust Everywhere category more than tripled to 700. Shares now trade at a 6.6x price-to-sales ratio, near the lowest level since its 2018 IPO.

Analysis

The selloff is less about the quarter and more about the market repricing execution risk in a category where growth durability is the only real multiple support. When a vendor with a high-visibility land-and-expand model guides below current run-rate after senior sales churn, investors usually extrapolate a 2-3 quarter productivity gap into a multi-year deceleration; that creates forced de-rating even if underlying demand remains intact. The second-order effect is that buyers of security budgets may now bargain harder across the entire zero-trust stack, delaying deal closure and increasing competitive pressure on renewal pricing.

This is a relative winner setup for larger platform vendors with broader distribution and more cross-sell leverage. If Zscaler’s field motion stumbles, peers with fuller suites can absorb some displaced spend by bundling identity, endpoint, SASE, and cloud security into one procurement decision; that should help PANW and CRWD more than pure-play point solutions over the next 1-2 quarters. The key nuance is that the market may be overestimating how much of Zscaler’s issue is structural versus a temporary sales-coverage reset; if pipeline conversion stays healthy, the current move could reverse quickly because sentiment is now anchored to worst-case guidance rather than trailing demand.

The contrarian setup is that zero-trust adoption is still early enough that a single management hiccup can distort perceived TAM velocity. If the company re-accelerates bookings or shows stable net retention through the next two quarters, the stock can rerate sharply from a depressed sales multiple because positioning is likely already de-risked. But if guidance proves accurate, the downside is not just lower growth; it would imply the market should haircut adjacent cybersecurity names where premium multiples still assume smooth execution.

Key Decisions for Investors

• Wait for post-event stabilization before buying ZS; consider scaling in only if the stock holds the gap-down low for 1-2 weeks and management confirms pipeline and renewal resilience. Risk/reward improves materially if the market has already priced the full guidance cut.
• Pair trade: long PANW / short ZS for 1-3 months. Thesis: broader platform breadth and distribution should capture share from any enterprise buying hesitation, while ZS carries higher execution risk. Use a tight stop if ZS reaccelerates bookings commentary.
• Tactical long CRWD vs ZS for 1-2 quarters. If security budgets consolidate around fewer vendors, CRWD’s broader endpoint plus identity adjacency offers more cross-sell capture and less dependence on a single sales motion.
• For aggressive contrarians, sell out-of-the-money ZS puts 2-3 months out only if implied volatility remains elevated. This expresses a view that the market has over-discounted temporary sales disruption; downside is assignment if guidance revisions prove sticky.
• Avoid adding to ZS until next quarter’s commentary on sales turnover and quota attainment. If the company shows sequential improvement, upside can be significant from a compressed multiple; if not, the de-rating likely has another leg down.